Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.AuthorsGhelardi, Filippo; Raimondi, Alessandra; Morano, Federica; Randon, Giovanni; Pannone, Alessandra; Guaglio, Marcello; Mazzoli, Giacomo; Nasca, Vincenzo; Milione, Massimo; Leoncini, Giuseppe; Sabella, Giovanna; Greco, Gabriella Francesca; Lampis, Bianca Rosa; Galassi, Margherita; Delfanti, Sara; Nannini, Margherita; Intini, Rossana; Baratti, Dario; Di Bartolomeo, Maria; Deraco, MarcelloPublicationClinical Colorectal Cancer, 2023, Vol 22, Issue 4, p450ISSN1533-0028Publication typeArticleDOI10.1016/j.clcc.2023.08.005